MRK Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '26 View

Key Takeaways MRK posted Q4 adjusted EPS of $2.04 and revenues of $16.40B, beating estimates for both metrics.MRK's Q4 revenues grew 5% to $16.40B, led by oncology, new drugs and Animal Health segment.MRK's 2026 outlook falls short of investors' expectations in terms of revenues and earnings.Merck (MRK) reported fourth-quarter 2025 adjusted earnings per share (EPS) of $2.04, which beat the Zacks Consensus Estimate of $2.03. Earnings increased 19% year over year, both on a reported basis and excluding foreig ...